M. Lindblad

发表

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

J. Petersen, C. Czerkinsky, J. Holmgren, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination)

J. Holmgren, A. Svennerholm, M. Lindblad, 1983, Infection and immunity.

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.

J. Holmgren, G. Wallerström, Y. Yang, 2001, Vaccine.

Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization

J. Holmgren, Yonghong Yang, T. Lagergård, 2001, Infection and Immunity.

Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.

J. Holmgren, Y. Yang, T. Lagergård, 2000, Vaccine.

Systemic and Mucosal Immune Responses in Mice after Mucosal Immunization with Group B Streptococcus Type III Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccine

J. Holmgren, Yonghong Yang, T. Lagergård, 2000, Infection and Immunity.

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I‐restricted cytotoxic T cells and the rejection of a cognate antigen‐expressing model tumor

J. Holmgren, K. Eriksson, M. Fredriksson, 2004, European journal of immunology.

Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co‐administration with free toxin as adjuvant

C. Czerkinsky, J. Holmgren, M. Fredriksson, 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization

J. Holmgren, J. P. McGee, M. Lindblad, 1995 .

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

T. Lehner, Carl-Fredrik Flach, C. Czerkinsky, 2005, Immunology letters.

Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin

J. Holmgren, A. Svennerholm, L. Svennerholm, 1982, Infection and immunity.

Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.

J. Holmgren, L. Svennerholm, J. Tayot, 1981, European journal of biochemistry.

Purification of El Tor cholera enterotoxins and comparisons with classical toxin.

J. Holmgren, R. Dubey, M. Lindblad, 1990, Journal of general microbiology.

Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay

J. Holmgren, A. Svennerholm, M. Wikström, 1986, Journal of clinical microbiology.

Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues

C. Czerkinsky, J. Holmgren, M. Russell, 1989, Infection and immunity.

Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates

J. Holmgren, T. Lagergård, M. Lindblad, 1995, Infection and immunity.

Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.

C. Czerkinsky, J. Holmgren, H. Link, 2000, International immunology.

Cholera Toxin B Subunit as Transmucosal Carrier‐Delivery and Immunomodulating System for Induction of Antiinfectious and Antipathological Immunity a

C. Czerkinsky, M. Lebens, J. Holmgren, 1996, Annals of the New York Academy of Sciences.

Large-Scale Production of Vibrio cholerae Toxin B Subunit for Use in Oral Vaccines

M. Lebens, J. Holmgren, J. Osek, 1993, Bio/Technology.

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice

C. Czerkinsky, J. Holmgren, M. Fredriksson, 2000 .

Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.

J. Holmgren, C. Ebner, B. Jahn-Schmid, 1999, International immunology.

Synthesis on nontoxic, antibody-binding Escherichia coli heat-stable enterotoxin (STa) peptides

J. Holmgren, A. Svennerholm, B. Svennerholm, 1988 .

Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine.

J. Holmgren, L. Svennerholm, P. Fredman, 1985, Gastroenterology.

Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.

J. Holmgren, K. Eriksson, M. Lindblad, 2004, Clinical immunology.

Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.

M C Davies, A. Coombes, M. Davies, 1997, Biomaterials.

Cholera and Oral-Mucosal Anti-infectious and Anti-inflammatory Vaccines

C. Czerkinsky, M. Lebens, J. Holmgren, 1996 .

Oral tolerization with peptide 336–351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease

T. Whittall, L. Bergmeier, T. Lehner, 2004, Clinical and experimental immunology.

Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin.

J. Holmgren, A. Svennerholm, M. Wikström, 1986, Medical biology.

GM1 ELISA method for demonstration of Escherichia coli heat-stable enterotoxin

A. Svennerholm, M. Lindblad, 1985 .

New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines

N. Mielcarek, C. Czerkinsky, M. Bäckström, 1998 .

Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin.

E. Fenyö, J. Holmgren, A. Harandi, 2008, Current HIV research.

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.

C. Czerkinsky, J. Holmgren, J. Sun, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Novel Immunostimulatory Agent Based on CpG Oligodeoxynucleotide Linked to the Nontoxic B Subunit of Cholera Toxin1

J. Holmgren, A. Harandi, A. Lundqvist, 2006, The Journal of Immunology.

Nontoxic B Subunit of Cholera Toxin CpG Oligodeoxynucleotide Linked to the Novel Immunostimulatory Agent Based on

J. Holmgren, A. Harandi, M. Lindblad, 2006 .